Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10305678 | Psychiatry Research: Neuroimaging | 2015 | 16 Pages |
Abstract
Twenty-five youth with attention-deficit/hyperactivity disorder (ADHD) were scanned with functional magnetic resonance imaging (fMRI) while performing a Go/No-go task before and after 6-8 weeks of randomized once-daily treatment with either the α2A-adrenergic receptor agonist guanfacine or placebo. Clinical improvement was greater for guanfacine than placebo and was differentially associated with reduced activation for guanfacine compared with placebo in the right midcingulate cortex/supplementary motor area and the left posterior cingulate cortex.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Anne-Claude V. Bédard, Kurt P. Schulz, Beth Krone, Juan Pedraza, Stephanie Duhoux, Jeffrey M. Halperin, Jeffrey H. Newcorn,